2018
DOI: 10.3390/antib7040039
|View full text |Cite
|
Sign up to set email alerts
|

Isolation and Characterization of Nanobodies against a Zinc-Transporting P-Type ATPase

Abstract: P-type ATPases form a large and ubiquitous superfamily of ion and lipid transporters that use ATP (adenosine triphosphate) to carry out their function. The IB subclass (PIB-ATPases) allows flux of heavy metals and are key players in metal detoxification, critical for human health, crops, and survival of pathogens. Nevertheless, PIB-ATPases remain poorly understood at a molecular level. In this study, nanobodies (Nbs) are selected against the zinc-transporting PIB-ATPase ZntA from Shigella sonnei (SsZntA), aimi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 26 publications
0
6
0
Order By: Relevance
“…Targeting and modulating pathogen-derived P-type ATPases is a promising strategy for the development of new antibiotics, antifungals, vaccines and herbicides, as these ATPases play important roles in the survival of pathogens ( Table 2 ) [ 113 ]. The immunization of a llama with purified SsZntA and panning on biotinylated SsZntA resulted in the identification of multiple SsZnt-targeting nanobodies that could be grouped into three families [ 114 ]. One of the retrieved SsZntA-targeting nanobodies could selectively target the ZntA ATPase and significantly reduced its pump function by up to 50% [ 114 ].…”
Section: Antibodies and Nanobodies To Target Cell Plasma Membrane mentioning
confidence: 99%
See 2 more Smart Citations
“…Targeting and modulating pathogen-derived P-type ATPases is a promising strategy for the development of new antibiotics, antifungals, vaccines and herbicides, as these ATPases play important roles in the survival of pathogens ( Table 2 ) [ 113 ]. The immunization of a llama with purified SsZntA and panning on biotinylated SsZntA resulted in the identification of multiple SsZnt-targeting nanobodies that could be grouped into three families [ 114 ]. One of the retrieved SsZntA-targeting nanobodies could selectively target the ZntA ATPase and significantly reduced its pump function by up to 50% [ 114 ].…”
Section: Antibodies and Nanobodies To Target Cell Plasma Membrane mentioning
confidence: 99%
“…The immunization of a llama with purified SsZntA and panning on biotinylated SsZntA resulted in the identification of multiple SsZnt-targeting nanobodies that could be grouped into three families [ 114 ]. One of the retrieved SsZntA-targeting nanobodies could selectively target the ZntA ATPase and significantly reduced its pump function by up to 50% [ 114 ]. However, the mechanism-of-action of this inhibition is not yet fully understood [ 114 ].…”
Section: Antibodies and Nanobodies To Target Cell Plasma Membrane mentioning
confidence: 99%
See 1 more Smart Citation
“…PIB-type ATPase lpg1024 (LpCopA) from L. pneumophila demonstrated that Cu 2+ ion-entry path involves two ion-binding sites: one transient Met148-Cys382 site and one intramembranous site formed by trigonal coordination to Cys384, Asn689, and Met717 [27]. One nanobodies (Nbs) selected against the zinc-transporting PIB-2-ATPases ZntA from Shigella sonnei (SsZntA), signi cantly reduces the ATPase activity [28]. The multifunctional P1B-4-ATPase CzcP is part of the cobalt, zinc, and cadmium resistance system from the metal-tolerant, model organism Cupriavidus metallidurans, because of an evolutionarily adapted exibility in the TM region likely afforded CzcP the ability to transport Cd 2+ and Zn 2+ in addition to Co 2+ [29].…”
Section: Introductionmentioning
confidence: 99%
“…Further exploiting their ability of bind to cavities and active sites of the target protein, with Nb9, the authors identified a highly selective inhibitor of the ATPase activity of SsZntA. These nanobodies provide a versatile toolset for structural and functional studies of this subset of ATPases [7]. Focusing on more therapeutic application, nanobodies can be a rich source of neutralizing anti-viral reagents.…”
mentioning
confidence: 99%